BB
BB Biotech Portfolio holdings
AUM
$3.98B
1-Year Return
15.06%
This Quarter Return
+3.08%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$3.55B
AUM Growth
-$61.4M
(-1.7%)
Cap. Flow
+$132M
Cap. Flow
% of AUM
3.73%
Top 10 Holdings %
Top 10 Hldgs %
70.18%
Holding
30
New
3
Increased
10
Reduced
6
Closed
–
Top Buys
| 1 |
Wave Life Sciences
WVE
|
$30M |
| 2 |
Voyager Therapeutics
VYGR
|
$25.6M |
| 3 |
CELG
Celgene Corp
CELG
|
$25M |
| 4 |
AKCA
Akcea Therapeutics, Inc. Common Stock
AKCA
|
$21.7M |
| 5 |
Esperion Therapeutics
ESPR
|
$17.4M |
Top Sells
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$8.24M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$7.62M |
| 3 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$5.94M |
| 4 |
Halozyme
HALO
|
$2.15M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$1.72M |
Sector Composition
| 1 | Healthcare | 92.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FPRX
26
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $18.1M | 0.51% |
827,500
+50,000
| +6% | +$1.1M |
|
27
Cidara Therapeutics
CDTX
$1.62B
| $15.6M | 0.44% |
114,764
+48,000
| +72% | +$6.53M |
|
28
Prothena Corp
PRTA
$441M
| $13.1M | 0.37% |
350,000
| – | – |
|
29
Novavax
NVAX
$1.24B
| $10.3M | 0.29% |
416,500
| – | – |
|
|
ACHN
30
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $3.68M | 0.1% |
1,279,340
| – | – |
|